HAMI 3379 [1245653-57-9]

TargetMol Chemicals

HAMI 3379 [1245653-57-9]

44

1245653-57-9

Research Use Only

HAMI 3379

C34H45NO8

595.72

HAMI 3379 (HAMI3379) is a selective cysteinyl leukotriene receptor 2 (CysLT2) antagonist that dose- and time-dependently attenuates brain damage and inhibits microglial cell inflammation following focal cerebral ischemia in rats and attenuates ischemia-like neuronal damage by inhibiting microglial activation.

3 years

OC(=O)[C@H]1CCC[C@@H](C1)NC(=O)c1cc(ccc1OCCCc1ccc(OCCCCOC2CCCCC2)cc1)C(O)=O

-20°C

12352200